Clinical-Pathologic Challenges in the Classification of Pulmonary Neuroendocrine Neoplasms and Targets on the Horizon for Future Clinical Practice

J.L. Derks*, N. Rijnsburger, B.C.M. Hermans, L. Moonen, L.M. Hillen, J.H. von der Thusen, M.A. den Bakker, R.J. van Suylen, E.J.M. Speel, A.M.C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1632-1646
Number of pages15
JournalResearch in Social & Administrative Pharmacy
Volume16
Issue number10
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • Pulmonary NENs
  • NET
  • Neuroendocrine carcinoma
  • Diagnosis
  • Molecular markers
  • CELL LUNG-CANCER
  • HIGH PROLIFERATIVE ACTIVITY
  • SOCIETY EXPERT CONSENSUS
  • MULTICENTER-PHASE-II
  • CARCINOID-TUMORS
  • PROGNOSTIC-SIGNIFICANCE
  • MOLECULAR SUBTYPES
  • PD-L1 EXPRESSION
  • SCLC
  • DIAGNOSIS

Cite this